Managing the risk in clinical trials is a hot topic today, but how should it be done, how effective is it, and how do we demonstrate value for our investment?
This presentation outlines the current or transitional approach to risk management and where this could mislead. It moves on to consider the variability inherent within clinical trials and the importance of understanding this in risk management. The final section covers risk mitigation and some of the benefits which can accrue from employing an effective risk management strategy in clinical study delivery.
Effective Risk Management: The Cost of Prevention? was previously presented by Rob Davie, PhD, Vice President, Clinical Service Delivery & Clinical Development Services, Europe, with Covance. For more details or to download this conference, please visit our site at www.fxconferences.com
